COVID-19 COMPASS study conducted by the University of Cincinnati Division of Infectious Diseases

U.C. HEALTH – ADVISORY

CINCINNATI, OH (July 14, 2021) – In an advisory released by the University of Cincinnati Health today, it was announced recruitment for an NIH funded COVID-19 Compass Study will take place at Jungle Jim’s in Eastgate 10:30-11:30 a.m. Thursday, July 15.  

Here is the information provided by the University of Cincinnati: 

What: Recruitment for the NIH-funded COVID-19 COMPASS study conducted by the University of Cincinnati Division of Infectious Diseases

When: Thursday, July 15 from 10 a.m. to 11:30 a.m.

Where: Jungle Jim’s Eastgate location. A study booth will be set up immediately inside the main entrance

Background on the study: “The NIH reached out to individual sites already involved in COVID-19 clinical trials and asked us to participate in this next level of study,” said Margaret Powers-Fletcher, PhD, assistant professor in the Division of Infectious Diseases at the UC College of Medicine and lead researcher on the study. “The goal is to better understand the impact of COVID-19 on the communities where these interventional trials are happening so that we can understand the data from those trials and better plan future trials more effectively.”

Powers-Fletcher says the goal is to enroll 4,000 people in Cincinnati in the COMPASS study as part of a nationwide target of 66,000 enrollees. People enrolled in the study will be asked to complete a brief questionnaire, provide a small blood sample and have a nasal swab to test for COVID-19. Those actions will all take place in one site visit. Enrollment for this study ends on July 31, 2021.

Who: Delia Miller, Sr. Clinical Research Professional, Infectious Diseases Division in the UC College of Medicine will be available for interviews. There may be the chance to interview some of the study participants as well.